Search the Newsreel

Jasper Therapeutics Inc (JSPR) Income Statement

This article provides the quarterly and annual income statements for Jasper Therapeutics Inc (JSPR), detailing various financial metrics such as operating expenses, R&D expenses, operating profit, and net income from FY2020Q3 to FY2026Q1. It also includes comprehensive FAQs on how to interpret the income …

Aspinwall & Co AGM approves director appointments and dividend

ASP Isotopes Market Sentiment

This article provides an overview of market sentiment for ASP Isotopes (ASPI), including analyst consensus, short interest, options flow, and insider activity. Key signals indicate a "Buy" consensus from analysts with an average price target of $10, while short interest is rising and insider …

Aspire Biopharma Holdings Inc (ASBP) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a detailed risk assessment for Aspire Biopharma Holdings Inc (ASBP), covering volatility metrics, financial health, and investment risk. It presents various data points such as Beta vs S&P 500, maximum drawdown, realized volatility, Sharpe Ratio, and daily return/loss figures over different …

Jasper Therapeutics Inc (JSPR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a detailed risk assessment for Jasper Therapeutics Inc (JSPR), focusing on volatility, financial risk, and investment risk. It presents various financial metrics including Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, and Liquidity indicators over different timeframes. The data shows significant volatility …

ASP Isotopes, Inc. Revenue Breakdown – DUS:W62

The article provides a revenue breakdown for ASP Isotopes, Inc. (DUS:W62), noting that the company generated 20.31 million EUR last year. Its top-performing segment, Construction Services, contributed 15.47 million EUR, with Hong Kong accounting for the entirety of this contribution. The data highlights segments …

ASPN,DMRC Volatility & Greeks

This article provides a detailed financial overview of Aspen Aerogels Inc (ASPN) and Digimarc Corp (DMRC), including their stock performance, key financial metrics, and market data as of July 27. It lists various ratios, growth rates, insider and institutional ownership, and analyst recommendations for …

Aspire Biopharma Holdings Inc (ASBP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical data on dividends and stock splits for Aspire Biopharma Holdings Inc (ASBP). It indicates that ASBP has not distributed any dividends in the past five years but lists two recent merger-related stock splits. The company's current stock price and market …

Jasper Therapeutics Inc (JSPR) Valuation: PE, PB & Fair Value Analysis

This article from TradingKey provides a valuation overview for Jasper Therapeutics Inc (JSPR), stating that relevant data for P/E, P/B, and P/CF ratios have not yet been disclosed by the company. It notes a recent stock price of $0.688, down 5.58%, with a market …

Jasper Therapeutics Inc (JSPR) Cash Flow Statement

This article provides detailed quarterly and annual cash flow statements for Jasper Therapeutics Inc (JSPR), covering operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flows and their significance for investors. The company's stock symbol is JSPR, …

Aspire Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:ASBP

This article provides financial information for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) on TradingView, focusing on revenue breakdown. It highlights the company's financial overview, statements, statistics, dividends, earnings, and segment performance.

Jasper Therapeutics, Inc. Revenue Breakdown – NASDAQ:JSPR

This article provides a basic overview of Jasper Therapeutics, Inc. (NASDAQ: JSPR) focusing on its financial data and market information available on TradingView. It indicates that the primary content, likely detailed revenue breakdown and other financials, would be accessible through the platform's various tools …

ASP Isotopes Inc (ASPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of ASP Isotopes Inc (ASPI), highlighting its current price momentum score of 5.86 within the Pharmaceuticals industry. It details the stock's trading range between a resistance level of $5.84 and a support level of $2.76, making it suitable …

ASPI|ASP Isotopes Inc|Price:3.870|Chg%:-0.170

ASP Isotopes Inc. (ASPI) is a development-stage advanced materials company focused on producing isotopes for various industries, including healthcare, technology, and nuclear fuels. While the company exhibits strong fundamentals like high revenue and net income growth (averaging 5407.52% and totaling $23.85M respectively), its stock …

ASPN|Aspen Aerogels Inc|Price:4.670|Chg%:-0.495

This article provides a detailed financial overview of Aspen Aerogels Inc (ASPN), offering insights into its income statement, balance sheet, and cash flow statement. It highlights the company's latest earnings reports, including revenue, EPS, net profit, and various financial ratios like net margin, gross …

ASBP|Aspire Biopharma Holdings Inc|Price:7.260|Chg%:+0.050

Aspire Biopharma Holdings Inc. (ASBP) shows strong fundamentals and high growth potential, though its valuation is considered fairly valued within the Biotechnology & Medical Research industry. Institutional ownership is very high, and the stock is expected to trend upwards in the medium term, having …

JSPR|Jasper Therapeutics Inc|Price:0.689|Chg%:-0.041

Jasper Therapeutics Inc (JSPR) closed at $0.688 with a 5.58% decrease on July 24, 2026. The company, a clinical-stage biotechnology firm, focuses on developing therapeutics for mast cell-driven diseases and severe combined immunodeficiency, with briquilimab as its lead product candidate. Analysts currently rate JSPR …

PT Bank Kasikorn Indonesia Tbk Revenue Breakdown – IDX:BMAS

Enterprise value to EBITDA forward of Jasper Therapeutics, Inc. – NASDAQ:JSPRW

This article focuses on the enterprise value to EBITDA forward for Jasper Therapeutics, Inc. (NASDAQ:JSPRW). It appears to be a financial data snippet from TradingView, indicating specific data points for certain periods. The content itself provides the title and mentions "Period," "Value," "Change," and …

Aspen Aerogels, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call

Aspen Aerogels, Inc. (NYSE: ASPN) has announced that it will release its second quarter financial results for the period ending June 30, 2026, on Thursday, August 6, 2026, before the market opens. Following the release, President & CEO Don Young and CFO & Treasurer …

Aspen Aerogels Expects Q2 Results Before Aug. 6 Open

Aspen Aerogels (NYSE: ASPN) announced it will release its second-quarter 2026 financial results before the market opens on Thursday, August 6, 2026. Management will then host a conference call at 8:30 a.m. ET to discuss the results, with access available via dial-in numbers and …

Jasper Therapeutics (JSPR) CMO lists merger-based stock option awards

Jasper Therapeutics' Chief Medical Officer, Greg Keenan, has reported initial equity holdings following the merger with Kira Pharmaceuticals. The holdings include stock options for Voting Common Stock and Non-Voting Convertible Preferred Stock, received in exchange for Kira options. These options start vesting in monthly …

Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statement

Jasper Therapeutics COO Matthew E. Ros has filed an initial beneficial ownership statement, reporting stock options for 103,204 voting common shares at a price of USD 0.01. This information was generated using AI based on data from the U.S. Securities and Exchange Commission's EDGAR …

Aspire Biopharma (ASBP) Financials 2026 - Income Statement and Balance Sheet

Aspire Biopharma (ASBP) showed improved liquidity and modest revenue growth in Q1 2026, driven by significant capital raises. Despite these positive developments, the company continues to report substantial operating losses and relies heavily on external financing. Its financial profile suggests a high-risk investment due …

Jasper Therapeutics (JSPR) COO buys non-voting convertible preferred shares

Jasper Therapeutics' Chief Operating Officer, Matthew E. Ros, purchased 881 shares of Non-Voting Convertible Preferred Stock on July 20, 2026, via a private placement. These preferred shares are convertible into 61 shares of Voting Common Stock each, subject to stockholder approval and a beneficial …

Form 4 Jasper Therapeutics Inc For: 22 July By Investing.com

This article reports on a Form 4 filing for Jasper Therapeutics Inc. on July 22. It indicates that the company's stock symbol is JSPR, which experienced a -3.25% change. The content primarily consists of market data and related news beyond the immediate Form 4 …

Jasper Therapeutics (JSPR) COO discloses merger-converted option stakes

Jasper Therapeutics' COO, Matthew E. Ros, reported initial derivative holdings following Kira Pharmaceuticals' merger into a Jasper subsidiary. These holdings include options to purchase 103,204 shares of Jasper voting common stock and 92,278 shares of non

Jasper Therapeutics (JSPR) EVP outlines option and preferred stakes after Kira deal

Jasper Therapeutics EVP Wenru Song has reported her equity positions following the merger of Kira Pharmaceuticals into a Jasper subsidiary. Her holdings include converted Kira options for Jasper's Voting Common Stock and Non-Voting Convertible Preferred Stock, with varying exercise prices and full vesting. Additionally, …

ASPN stock holds support after recent Aerogel update

This article states that Aspen Aerogels (ASPN) stock is holding support following an update related to its Aerogel context. The piece emphasizes that with no current verifiable quote or fresh company release, investors should monitor official investor relations communications for updates on revenue conversion, …

ASP Isotopes (NDRA) outlines Noble Africa–ENDRA merger and $750M project funding

ASP Isotopes, through its subsidiaries Renergen and Noble Africa, detailed a proposed merger with ENDRA Life Sciences to create a separately listed, pure-play helium business on Nasdaq. This new entity will leverage Renergen's Virginia Gas Project in South Africa, which boasts high helium concentrations …

ASP Isotopes Inc. (ASPI) stock price, news, quote and history

This Yahoo Finance page provides a comprehensive overview of ASP Isotopes Inc. (ASPI) stock, detailing its current price, historical data, financial performance, and company profile. It includes key metrics such as market capitalization, trading ranges, volume, and analyst recommendations, alongside a description of the …

ASP Isotopes | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions - moomoo

This document is an SEC filing under Securities Act Rule 425 for ASP Isotopes, related to prospectuses and communications concerning business combination transactions. It indicates a regulatory filing regarding corporate mergers or acquisitions.

ASPI: Phase I helium shipments begin September amid global shortages, with major growth ahead

ASPI Noble Africa is set to begin Phase I helium shipments in September, positioning the company for significant growth amidst severe global shortages and record prices for helium. The project involves a world-class helium and LNG facility in South Africa. The company's strong outlook …

Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filing

(RTTNews) - Today's top biotech gainers include Wellgistics following its rebranding, Femasys, which recently resolved its Nasdaq compliance issue, Vor Bio with continued progress in its Telitacicept program, and Sol-Gel Technologies as investors look ahead to key SGT-610 Phase 3 data, among others. Read …

ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production

ASP Isotopes is planning to create Noble Africa, a publicly listed helium and LNG platform, through a merger with ENDRA Life Sciences, with ASP expected to own about 89% of the combined company. The project's Phase 1, leveraging Renergen's high-grade South African helium resource, …

Kaspi.kz JSC Sponsored ADR RegS (KSPI) Q3 2023 Earnings Report - Results, Call & Slides

This article provides an overview of Kaspi.kz JSC Sponsored ADR RegS (KSPI) Q3 2023 earnings report. The company significantly beat analyst expectations with an actual EPS of $2.24 against a consensus of $1.72 and actual revenue of $1.12 billion against an expected $627.99 million. …